maternal and foetal circulation systems; (b) immuno-protection and releasing of chemicals necessary for pregnancy progress. It is undeniable that, as a new foeto-maternal vascular organ, the maintenance of placental functions is dependent on sufficient placental perfusion and adequate blood flow via placental circulatory system. 6 Generally, this system includes a placental vascular tree (composed of chorionic plate arteries and their branches, terminal villi and veins). 6 Vascular tone in this system is essential for maintaining adequate placental blood flow. Because placental vessels lack autonomic innervation, 7 local vasoconstrictors and vasodilators are of paramount importance for controlling blood flow in placental circulation. Abnormalities in constriction and relaxation of the placental vasculature will affect blood flow in the placenta, contributing to placental ischaemia and an abnormal course of pregnancy such as PE. 8, 9 Therefore, the abnormal vascular reactivity of endogenous vaso-activators in pre-eclamptic placental vasculature offers interesting model for investigations of mechanisms as well as targets of treatments for PE. However, so far, there has been limited information on the abnormal vascular reactivity of endogenous vaso-activators such as oxytocin (OXT) in pre-eclamptic placental vasculature.
Oxytocin is a nine-amino acid neuropeptide that is known to play a critical role in foetal expulsion and breastfeeding, and has been recently implicated in mammalian social behaviour. 10, 11 The actions of both central and peripheral OXT are mediated through oxytocin receptor (OXTR), which is encoded by a single gene. In the context of pregnancy, OXT and OXTR are rich in the human placenta. 10, 12 There is an increase in OXT concentrations in maternal plasma and the placenta with the onset of labour. 10, 11 As a classical vasoconstrictor, OXT is predominantly known as a potent stimulator of uterine smooth muscle, and studies on isolated placental vessels have suggested an important role for this compound in the maintenance of placental vascular tone and circulation. 13 However, information about the reactivity of OXT in pre-eclamptic placental vasculature is limited. This was the first study using a large number of human placental vessels, to reveal the pathophysiological changes and its underlying mechanisms of OXT-induced vasoconstrictions in placental vessels under the pre-eclamptic condition, which would provide new information for better understanding the pre-eclamptic placental vascular dysfunctions and placental ischaemia.
| MATERIAL S AND ME THODS

| Patients and samples
Placenta specimens of normal (NP, N = 45) or pre-eclamptic pregnancy Pre-eclamptic pregnancies were defined by the onset of hypertension during pregnancy (blood pressure ≥ 140/90 mm Hg, with no prior hypertension history) and consistent proteinuria (≥300 mg/d). 1, 14 The clinical characteristics of all participants were summarized in Table 1 .
| Vascular functional studies
Placental tissue were kept in iced Krebs solution (containing in mmol/L: NaCl 119, NaHCO3 25, glucose 11, KCl 4.7, KH2PO4 1.2, MgSO4 1.0 and CaCl2 2.5), and bubbled with 95% O2 and 5% CO2.
Human placental vessels (HPV) (HPV-A1/A2, first-, second-order branch of blood vessels in the placenta, mainly the main stem villous arteries; HPV-A3, branch of the main stem villous arteries with diameter around 100 m) were carefully isolated. HPV were cut into rings approximately 3-5 mm in length and mounted in a multi-myograph system for recording of isometric tension (PowerLab 16/SP and Chart 5). 15 Vessel rings were adjusted to maintain a suitable passive force and equilibrated for 60 minutes. Potassium chloride (KCl, 120 mmol/L) was used to achieve optimal resting tension before adding drugs. The contractions elicited by KCl were a reference for contractile capacity in response to drugs. 16 The vessel rings were contracted with cumula- 
| DNA isolation and targeted bisulphite sequencing assay
To prepare genomic DNA, homogeneous HPV were lysed with the lysis buffer containing (10 mmol/L Tris-Cl (pH 7.5), 10 mmol/L NaCl, 10 mmol/L EDTA, 0.5% sarcosyl, and 1 mg/ml proteinase K), and incubated overnight at 60°C. 
| Quantitative real-time PCR and Western blot analysis
Total RNA was isolated from placental vessels using Trizol reagent, and was reversed transcribed using the first-strand cDNA Synthesis Kit (Invitrogen Corp., Carlsbad, CA, USA). Then, qRT-PCR was performed with the SYBR Green Supermix Taq Kit (Takara Biotechnology
Co., Ltd., Dalian, China) and analysed on an iQ5 Real-Time PCR Detection System (Bio-Rad Laboratories, Inc, Hercules, CA, USA).
∆∆Ct method was used to comparatively quantify the abundance of mRNA levels. The qRT-PCR primer sequences were listed in Table 3 .
The protein abundance of OXTR in placental vessels was assessed by Western blot analyses normalized to β-actin. Antibodies were purchased from Sigma-Aldrich or CST (Cell Signaling Technology, Inc China). All experiments were repeated three times with independently prepared tissue, and performed as previously described. 19 
| Data analysis and statistics
Data are presented as mean ± SEM, and analysed by a two-tailed Student's t test or two-way analysis of variance (ANOVA) followed by Bonferroni test using GraphPad Prism version 5 (GraphPad Software, San Diego, CA, USA), where appropriate. DNA methylation/mRNA correlation plot for OXTR gene was identified by causal inference test (SigmaPlot 10.0). Results were considered statistically significant when the P value was less than 0.05.
| RE SULTS
| Oxytocin-induced contractions in human placental vessels
In both HPV-A1/A2 and HPV-A3, there were no significant differ- and HPV-A3 from PE group, OXT-induced contractions were significantly decreased with a reduced maximal response and pD2 (−log [50% effective concentration]) as compared to NP group ( Figure 1A ,
C and E, P < 0.05). These data indicated that pre-eclamptic placental vessels were significantly insensitive to OXT.
| Expression of OXTR in human placental vessels
To investigate whether the decreased OXT-mediated vasoconstrictions were correlated with the altered OXTR expression in pre-eclamptic placental vessels, OXTR mRNA and protein levels were determined. As shown in Figure 2A -C, there was a significant decrease in protein of OXTR in both of HPV-A1/A2 and HPV-A3 from PE group.
To determine whether OXTR expression was regulated through transcriptional mechanism, we measured the mRNA abundance of OXTR.
Figure 2B-D showed that compared with NP group, the mRNA levels of OXTR in HPV-A1/A2 and HPV-A3 were decreased in PE group. These data suggested that the decreased sensitivity to OXT in pre-eclamptic placental vessels was correlated with the down-regulated OXTR, and the deactivated transcription of OXTR gene.
| The effect of atosiban on OXT-induced contractions in human placental vessels
To further determine whether the decreased OXTR was associated with OXT-induced vasoconstrictions in PE group, vascular rings were pre-treated with atosiban (OXTR-specific antagonist). As shown in Figure 3 , atosiban almost completely blocked OXT-mediated contractions in both of HPV-A1/A2 and HPV-A3, without differences between NP and PE groups after pre-treated with atosiban, demonstrating that the decreased OXT-mediated vasoconstrictions in PE group were due to the down-regulated OXTR.
| DNA methylation of CpG locus at OXTR gene promoter in human placental vessels
The expression of a gene may be down-regulated through an increase in DNA methylation of its promoter, CpG islands. 
A B
Sequence analysis identified one CpG island that contains 22 CpG sites within exons of the OXTR gene ( Figure 4A ). OXTR located on chromosome 3p25. Table 2 provides a key for CpG labels. We validated methylation status for the 22 CpG sites with targeted bisulphite sequencing. The bisulphite conversion rate of each sample was higher than 99%, and no significant differences were found between NP and PE group, indicating the bisulphite conversion was efficient and reliable in the experiments ( Figure 4B ). By using targeted bisulphite sequencing that examined in vivo methylation pattern of CpG island region, we found that, compared to NP, mean methylation percentage of the total 22 CpG sites within OXTR gene promoter in PE group was remarkably increased (PE vs NP: 0.0760 ± 0.0022 vs 0.0919 ± 0.0014, P < 0.001; Figure 4C ), whereas, no significant difference was found in each tested CpG 
| D ISCUSS I ON
This study found that OXT-induced vascular contractions were significantly decreased in pre-eclamptic placental vasculature. The decreased sensitivity to OXT in pre-eclamptic vessels was correlated with the down-regulated OXTR, as well as the deactivated transcription of OXTR gene. OXTR gene transcription was linked with DNA methylation status of CpG islands in OXTR gene promoter. To the best of our knowledge, this is the first study to reveal that a hypermethylation of certain CpG islands in OXTR gene promoter led to a relatively reduced pattern of OXTR expression, which was responsible for the decreased sensitivity to OXT in placental vessels under pre-eclamptic conditions. Thus, the data not only offered new information for further understanding the pathological features and mechanisms of PE, but also underlined a role of epigenetic-mediated gene expression in pre-eclamptic placental vascular dysfunctions such as placental ischaemia.
In uterus, large (HPV-A1/A2) and small (HPV-A3) vascular branches in the placenta play a key role in maintaining a balance of placental circulation and provide adequate blood flow for development of foetus. Present data showed that in both pre-eclamptic large and small placental vessels, OXT-induced vascular contractions were significantly decreased with a reduced maximal response and pD2 as compared to normal pregnancy, indicating that pre-eclamptic placental vessels were significantly insensitive to OXT. To date, information about the reactivity of OXT in pre-eclamptic placental vessels was limited. One study in 1989 reported that OXT produced weak contractions in placental vessels, and no significantly differences in OXT-induced contractions between normal and pre-eclamptic placental vessels. 20 Based on these results, previous study suggested that the effects of OXT on placental vascular tone in human term pregnancy are negligible. However, considering huge variation in human participants and the sample size was small (only six per group), it is hard to confirm OXT effects on human placental vessels. The similar situations were noted regarding vascular effects of acetylcholine on placental vessels recently, as obvious controversy results existed before. 8, 16, 21, 22 To solve the problem, we significantly increased sample size in order to reach repeatable results. 15, 16 In the present study, the large number of human samples number of studies in humans and laboratory animals indicated that 
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